09/30/19 1 ADEL ARDAKANI PhD Date of Birth: April 16 th 1976 Mob: 079 5043650 Home Address: P. O. Box 141523 Work Address: Applied Science Private University Amman 11814 P. O. Box Amman 11931 Jordan Jordan Tel: ++ 962 6 5811721 ++ 962 6 5609999 ext. 1249 E-mail: adel_ardakani@yahoo.co.uk Ardakani@asu.edu.jo Martial status: Married Nationality: Jordanian RESEARCH & PUBLICATIONS  Currently working on a project regarding the chemical modification of Starch Polymer for Pharmaceutical Application in Drug Delivery systems as well as research in pharmacy education. 1. “Medicinal chemistry and the Bachelor of Pharmacy curriculum: Assessing student’ s perspectives, needs and barriers” Adel Ardakani, Iman A. Basheti. Tropical Journal of Pharmaceutical Research 17 (5), 927-935, 2018. 2. “In Vitro and in Vivo evaluation of Casein as a Drug Carrier for Enzymatically Triggered Dissolution Enhancement from Solid Dispersions” Ahmad Bani -Jaber, Iyad Alshwwabkeh, Samaa Abdullah, Imad Hamdan, Adel Ardakani, Maha Habash, American Association of Pharmaceutical Scientists PharmSciTech. Jul;18(5):1750-1759, 2017. 3. “Sustained release matrix tablets prepared from cospray dried mixtures with starch hydrophobic esters” N. Sakhnini, N. Al-Zoubi, G. H. Al-Obaidi, A. Ardakani, Pharmazie 70: p.177–182, 2015. 4. “Synthesis of A Novel Chitosan-Based Polymer And Application As A Matrix For Controlled Drug Delivery” Ardakani A, Al-Zoubi N, Sakhnini N, Taha MO, Jordan Journal of Pharmaceutical Sciences, Vol 6 (2) p.233-240, 2013. 5. “Tableting Functionality Evaluation of Prosolv Easytab; in Comparison to Physical Mixtures of its Individual Components”; Ahmad Aljaberi, Adel Ardakani, Ayman Khdair, Safwan A. Abdel-Rahim, Eman Meqdadi, Manal Ayyash, Ghada M. Alobaidi, Nizar Al-Zoubi, Journal of Drug Delivery Science and Technology, Vol 23 (5) p.499-504, 2013. 6. "Sodium Lauryl Sulfate Impedes Drug Release From Zinc-Crosslinked Alginate Beads: Switching From Enteric Coating", Mutasem O. Taha, Wissam Nasser, Adel Ardakani, Hatim S. AlKhateeb, International Journal of Pharmaceutics, Release Into Biphasic Profiles 350 (1), p.291-300, Feb 2008. 7. “Organocatalysis of Asymmetric Epoxidation Mediated by Iminium Salts under Nonaqueous Conditions”; Philip C. Bulman Page, David Barros, Benjamin R. Buckley, Adel Ardakani, and Brian A. Marples, J. Org. Chem., 69, 3595-3597, 2004. 8. “New Organocatalysts for the Asymmetric Catalytic Epoxidation of Alkenes Mediated by Chiral Iminium Salts”; Philip C. Bulman Page, Gerasimos A. Rassias, David Barros, Adel Ardakani, Donald Bethell, Eric Merifield, Synlett., 4, 580- 582, 2002. 9. “Functionalized Iminium Salt Systems for Catalytic Asymmetric Epoxidation”; Philip C. Bulman Page, Gerasimos A. Rassias, David Barros, Adel Ardakani, Benjamin Buckley, Donald Bethell, Timothy A. D. Smith, Alexandra M. Z. Slawin, J. Org. Chem., 66, 6926-6931, 2001. EDUCATION 1998-2002 Loughborough University, UK I have been awarded a PhD in Asymmetric Organic Synthesis under the supervision of Prof. P.C.B. Page, titled: “A New System for Catalytic Asymmetric Epoxidation” The aim of this project was the development of a range of iminium salts catalysts for asymmetric epoxidation, applicable to variety of alkene substrates. This involved the use of Chiral NMR & HPLC techniques. I was also involved in undergraduate laboratory demonstrations and supervision of part time students in our research group. 1995-1998 Loughborough University, UK B.Sc. (Hons) in Medicinal and Pharmaceutical Chemistry. Class 2.1 My final year project was based on organic synthesis; another minor project was aimed at the formulation in the pharmaceutical industry with a goal of developing my knowledge in understanding the research and development process of new & existing drugs. 1993-1995 Loughborough College, Loughborough, UK A Levels: Chemistry (A), Biology (B), Physics (B)